RLAY
NASDAQStockRelay Therapeutics, Inc.
$10.40-0.15 (-1.42%)
52-Week Range
$2.00
$10.80
Key Stats
Market Cap
1.9B
P/E Ratio
—
Dividend Yield
—
Beta
1.62
Volume
1.2M
Avg Volume
3.1M
Performance
1M
+19.75%
3M
+24.41%
6M
+159.85%
YTD
+28.97%
1Y
+188.25%
3Y
-36.06%
5Y
-73.30%
Price Chart
ETF Exposure
RLAY is held by 102 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | 1.21% |
| BBC | Virtus Biotech Clinical Trials ETF | 1.02% |
| CANC | Tema Oncology ETF | 0.97% |
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 0.88% |
| LRNZ | TRUESHARES TECHNOLOGY, AI & DEEP LEARNING ETF | 0.69% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.49% |
| CURE.AX | Global X - S&P Biotech ETF | 0.45% |
| XBI | State Street SPDR S&P Biotech ETF | 0.45% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.19% |
| DRDR.L | iShares Healthcare Innovation UCITS ETF | 0.19% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.19% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.17% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.14% |
| 2B77.DE | iShares Ageing Population UCITS ETF | 0.14% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.14% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.14% |
| IBB | iShares Biotechnology ETF | 0.12% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.12% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.11% |
| IWN | iShares Russell 2000 Value ETF | 0.11% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.10% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.10% |
| STSB | iShares Factors US Small Blend Style ETF | 0.08% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.07% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.07% |
| PWS | Pacer WealthShield ETF | 0.06% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.06% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.06% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.05% |
| IWM | iShares Russell 2000 ETF | 0.05% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.05% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.05% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.05% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.05% |
| CBUG.DE | iShares $ Treasury Bond 3-7yr UCITS ETF | 0.05% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.05% |
| DFAS | Dimensional - US Small Cap ETF | 0.04% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.04% |
| RSSL | Global X - Russell 2000 ETF | 0.04% |
| CUS1.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.04% |
| CUSS.L | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.04% |
| SXRG.DE | iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF | 0.04% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.04% |
| UWM | ProShares - Ultra Russell2000 | 0.04% |
| VTWO | Vanguard Russell 2000 ETF | 0.04% |
| URTY | ProShares - UltraPro Russell2000 | 0.03% |
| FSMO | Fidelity Small-Mid Cap Opportunities ETF | 0.03% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.03% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.03% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.03% |
Page 1 of 3Next
About RLAY ETF Exposure
Relay Therapeutics, Inc. (RLAY) is held by 102 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.9B, RLAY is a widely held institutional stock. The stock currently trades at $10.40. Investors can gain exposure to RLAY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RLAY, sorted by portfolio weight.